Orbimed Advisors LLC Crispr Therapeutics Ag Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $42.9 Million - $68.2 Million	-612,700 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $10.3 Million - $14.7 Million	93,700 Added 18.05%	612,700 $68.6 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $3.38 Million - $5.42 Million	-33,500 Reduced 6.06%	519,000 $84 Million
Q1 2021 May 17, 2021	BUY	$110.72 - $210.04 $11.1 Million - $21.2 Million	100,700 Added 22.29%	552,500 $67.3 Million
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $14.2 Million - $30.9 Million	-178,204 Reduced 28.29%	451,800 $69.2 Million
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $5.3 Million - $6.8 Million	-67,520 Reduced 9.68%	630,004 $52.7 Million
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $5.63 Million - $11.1 Million	146,324 Added 26.55%	697,524 $51.3 Million
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $7.25 Million - $13.5 Million	-215,178 Reduced 28.08%	551,200 $23.4 Million
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $9.17 Million - $18.3 Million	249,978 Added 48.41%	766,378 $46.7 Million
Q3 2019 Nov 14, 2019	BUY	$40.99 - $52.56 $21.2 Million - $27.1 Million	516,400 New	516,400 $21.2 Million
Q4 2018 Feb 14, 2019	SELL	$22.73 - $42.34 $11.3 Million - $21 Million	-496,200 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $16.7 Million - $28.8 Million	391,799 Added 375.28%	496,200 $29.2 Million
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $2.46 Million - $6.07 Million	104,401 New	104,401 $4.77 Million
Q4 2017 Feb 14, 2018	SELL	$16.95 - $23.48 $6.31 Million - $8.74 Million	-372,191 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$16.75 - $20.66 $6.23 Million - $7.69 Million	372,191	372,191 $6.65 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$320 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$303 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$121 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$120 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$120 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.15B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account